Dataset from A Randomized, Double-blind, Dose-adjustment, Placebo-controlled Study to Evaluate the Efficacy and Safety of Aripiprazole in Children and Adolescents With Chronic Tic Disorders or Tourette's Disorder
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/00006888
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this trial is to demonstrate the efficacy and safety of aripiprazole in
children and adolescents aged 6~18 years with chronic tic disorders or Tourette's disorder
创建时间：
2025-12-03
